His spit of fland medicine can lower the recuring rate of cancer biochemistry of prostate
Washington, June 28 (Xinhua) ' Reporter Ren HaiJun) American Duke University medical center researchers say on June 28, take his spit of fland and lower the recuring rate of biochemistry that cholesterol medicines can reduce prostate cancer notably. Researcher's follow-up investigation is 1319 patients who implement the effecting a radical cure prostate excision, have taken his spit of fland medicine before 236 people skills among them. After the operation, researchers measure specific antigenic level of prostate in patient's body, in order to assess its recuring rate of cancer biochemistry of prostate. The prostate -specific antigen is one of the marks of prostate tumour, measuring the prostate -specific antigen plays an important role in cancer patient's curative effect of prostate is assessed and followed up a case by regular visits to. Some prostate -specific antigen after skill of patient of effecting a radical cure excision treatment will rise in 5 years, biochemistry recurs. It is generally acknowledged, it is the manifestation initially that disease recurs that biochemistry recurs. Researcher find in all 304 patient the intersection of the prostate and specific antigenic competence rise in 5 years after the operation, the persons who among them take his spit of fland medicine 37 people, the persons who have not taken medicine are 267 people. Through correcting the multiple and clinical and dangerous factor of pathology, researchers think, his spit of fland medicine can reduce the postoperative recuring rate of biochemistry of cancer patient of prostate by 30%. This research results are issued on the latest " cancer " magazine. Stephen and Fred and Land participating in studying thinks, this research shows, his spit of fland medicine may play an important role in slowing down prostate cancer and growing and spreading the course.
|
No comments:
Post a Comment